{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:02:36Z","timestamp":1789624956227,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011649","name":"Japan Orthopaedics and Traumatology Foundation","doi-asserted-by":"publisher","award":["561"],"award-info":[{"award-number":["561"]}],"id":[{"id":"10.13039\/501100011649","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K0862303"],"award-info":[{"award-number":["23K0862303"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bone.2026.117776","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T07:40:42Z","timestamp":1767426042000},"page":"117776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["ITAM\u2013Syk signaling mediates the rebound phenomenon after anti-RANKL antibody discontinuation"],"prefix":"10.1016","volume":"205","author":[{"given":"Hotaka","family":"Ishizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoka","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomaya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimasa","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Amizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bone.2026.117776_bb0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00774-018-0928-x","article-title":"Potential association with early changes in serum calcium level after starting or switching to denosumab combined with eldecalcitol","volume":"37","author":"Asano","year":"2019","journal-title":"J. Bone Miner. Metab."},{"issue":"6","key":"10.1016\/j.bone.2026.117776_bb0010","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00223-023-01079-y","article-title":"Comparison of the efficacy of zoledronate acid or denosumab after switching from romosozumab in Japanese postmenopausal patients","volume":"112","author":"Oue","year":"2023","journal-title":"Calcif. Tissue Int."},{"issue":"4","key":"10.1016\/j.bone.2026.117776_bb0015","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1210\/jc.2010-1502","article-title":"Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass","volume":"96","author":"Bone","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2026.117776_bb0020","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jbmr.3337","article-title":"Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension","volume":"33","author":"Cummings","year":"2018","journal-title":"J. Bone Miner. Res."},{"issue":"10329","key":"10.1016\/j.bone.2026.117776_bb0025","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","article-title":"Drug therapy for osteoporosis in older adults","volume":"399","author":"Reid","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2026.117776_bb0030","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bone.2018.12.012","article-title":"Acute hypercalcemia and excessive bone resorption following anti-RANKL withdrawal: case report and brief literature review","volume":"120","author":"Roux","year":"2019","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bone.2026.117776_bb0035","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/jbmr.3110","article-title":"Clinical features of 24 patients with rebound-associated vertebral fractures after denosumab discontinuation: systematic review and additional cases","volume":"32","author":"Anastasilakis","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117776_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2017.08.003","article-title":"Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS","volume":"105","author":"Tsourdi","year":"2017","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.bone.2026.117776_bb0045","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1007\/s00198-019-05146-9","article-title":"Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab","volume":"30","author":"Kendler","year":"2019","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2026.117776_bb0050","article-title":"Romosozumab was not effective in preventing multiple spontaneous clinical vertebral fractures after denosumab discontinuation: a case report","volume":"13","author":"Kashii","year":"2020","journal-title":"Bone Rep."},{"issue":"3","key":"10.1016\/j.bone.2026.117776_bb0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/jbmr\/zjae170","article-title":"The effects of denosumab on osteoclast precursors in postmenopausal women: a possible explanation for the overshoot phenomenon after discontinuation","volume":"40","author":"Schini","year":"2025","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2026.117776_bb0060","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.humimm.2013.02.003","article-title":"Structure, expression pattern and biological activity of molecular complex TREM-2\/DAP12","volume":"74","author":"Paradowska-Gorycka","year":"2013","journal-title":"Hum. Immunol."},{"issue":"6","key":"10.1016\/j.bone.2026.117776_bb0065","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.4049\/jimmunol.177.6.3520","article-title":"Cutting edge: TREM-2 attenuates macrophage activation","volume":"177","author":"Turnbull","year":"2006","journal-title":"J. Immunol."},{"issue":"122","key":"10.1016\/j.bone.2026.117776_bb0070","doi-asserted-by":"crossref","first-page":"ra38","DOI":"10.1126\/scisignal.2000500","article-title":"TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1","volume":"3","author":"Peng","year":"2010","journal-title":"Sci. Signal."},{"issue":"6","key":"10.1016\/j.bone.2026.117776_bb0075","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1083\/jcb.200611083","article-title":"Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption","volume":"176","author":"Zou","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bone.2026.117776_bb0080","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3389\/fimmu.2019.00937","article-title":"Hematopoietic or osteoclast-specific deletion of Syk leads to increased bone mass in experimental mice","volume":"10","author":"Csete","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bone.2026.117776_bb0085","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fcell.2020.00507","article-title":"Osteoclast signal transduction during bone metastasis formation","volume":"8","author":"Gyori","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"18","key":"10.1016\/j.bone.2026.117776_bb0090","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167790","article-title":"Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation","volume":"8","author":"Fu","year":"2023","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.bone.2026.117776_bb0095","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00198-022-06651-0","article-title":"Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption","volume":"34","author":"S\u00f8lling","year":"2023","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.bone.2026.117776_bb0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41413-024-00362-4","article-title":"Mapping RANKL- and OPG-expressing cells in bone tissue: the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effect","volume":"12","author":"El-Masri","year":"2024","journal-title":"Bone Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226000025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226000025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:29:01Z","timestamp":1773898141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328226000025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":20,"alternative-id":["S8756328226000025"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2026.117776","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ITAM\u2013Syk signaling mediates the rebound phenomenon after anti-RANKL antibody discontinuation","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2026.117776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117776"}}